Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H J Kupferberg

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Advances in Neurology|January 1, 1980
Sodium valproateH J Kupferberg
Progress in Clinical and Biological Research|January 1, 1990
Preclinical drug development in the antiepileptic drug development program. A cooperative effort of government and industryH J Kupferberg
Pharmaceutisch Weekblad. Scientific Edition|June 19, 1992
Strategies for identifying and developing new anticonvulsant drugsH J Kupferberg
Epilepsia|January 1, 1989
Antiepileptic drug development program: a cooperative effort of government and industryH J Kupferberg
Journal of Pharmaceutical Sciences|February 1, 1972
GLC determination of carbamazepine in plasmaH J Kupferberg
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 1, 1970
Quantitative estimation of diphenylhydantoin, primidone and phenobarbital in plasma by gas-liquid chromatographyH J Kupferberg
Journal of Chromatography|June 11, 1979
Measurement of mephenytoin (3-methyl-5-ethyl-5-phenylhydantoin) and its demethylated metabolite by selective ion monitoringW Yonekawa, H J Kupferberg
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1975
The metabolism of 3-methyl-5-ethyl-5-phenylhydantoin (mephenytoin) to 5-ethyl-5-phenylhydantoin (Nirvanol) in mice in relation to anticonvulsant activityH J Kupferberg, W Yonekawa
Neurology|December 1, 1975
Isoniazid as an inhibitor of primidone metabolismG Sutton, H J Kupferberg
Epilepsia|December 1, 1979
Linear relationship between plasma concentration and dosage of sodium valproateJ G Nutt, H J Kupferberg
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Advances in Neurology|January 1, 1980
Sodium valproateH J Kupferberg
Progress in Clinical and Biological Research|January 1, 1990
Preclinical drug development in the antiepileptic drug development program. A cooperative effort of government and industryH J Kupferberg
Pharmaceutisch Weekblad. Scientific Edition|June 19, 1992
Strategies for identifying and developing new anticonvulsant drugsH J Kupferberg
Epilepsia|January 1, 1989
Antiepileptic drug development program: a cooperative effort of government and industryH J Kupferberg
Journal of Pharmaceutical Sciences|February 1, 1972
GLC determination of carbamazepine in plasmaH J Kupferberg
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 1, 1970
Quantitative estimation of diphenylhydantoin, primidone and phenobarbital in plasma by gas-liquid chromatographyH J Kupferberg
Journal of Chromatography|June 11, 1979
Measurement of mephenytoin (3-methyl-5-ethyl-5-phenylhydantoin) and its demethylated metabolite by selective ion monitoringW Yonekawa, H J Kupferberg
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1975
The metabolism of 3-methyl-5-ethyl-5-phenylhydantoin (mephenytoin) to 5-ethyl-5-phenylhydantoin (Nirvanol) in mice in relation to anticonvulsant activityH J Kupferberg, W Yonekawa
Neurology|December 1, 1975
Isoniazid as an inhibitor of primidone metabolismG Sutton, H J Kupferberg
Epilepsia|December 1, 1979
Linear relationship between plasma concentration and dosage of sodium valproateJ G Nutt, H J Kupferberg
Pageof 9